CURE » Bladder Cancer
3 FOLLOWERS
The bladder cancer condition center is a comprehensive resource for cancer news & oncologist insights on bladder cancer. Launched in 2002 for patients with cancer, survivors and their caregivers, CURE Media Group's flagship magazine and online resource curetoday.com provide access to leading resources and information that serve as a guide to every stage of the cancer experience
CURE » Bladder Cancer
2d ago
Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE ..read more
CURE » Bladder Cancer
2d ago
A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with non-muscle-invasive bladder cancer ..read more
CURE » Bladder Cancer
1w ago
The survival benefit observed with Padcev plus Keytruda was “unlike anything we’d seen before” for advanced bladder cancer, according to an expert ..read more
CURE » Bladder Cancer
3w ago
Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy ..read more
CURE » Bladder Cancer
3w ago
Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors ..read more
Olivia Munn Discusses Breast Cancer, Christine Brinkley Diagnosed With Basal Cell Carcinoma and More
CURE » Bladder Cancer
1M ago
From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week ..read more
CURE » Bladder Cancer
1M ago
Quality of life, sexual outcomes and self-image should be considered before choosing a treatment option for muscle-invasive bladder cancer, an expert said ..read more
CURE » Bladder Cancer
1M ago
The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder cancer, the agency has announced ..read more
CURE » Bladder Cancer
2M ago
A phase 2 trial showed that Trodelvy plus Keytruda had a high response rate with lasting responses, emphasizing “potential additive or synergistic effects,” an expert said ..read more
CURE » Bladder Cancer
2M ago
Treatment for muscle-invasive bladder cancer called dose-dense MVAC did not improve survival compared with chemotherapy alone, although one drug in the combination faces a shortage ..read more